Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Poster Session Abstracts

Abstract P6-09-32: The association of breast cancer subtype and breast cancer survival with parity and time since last birth

H De Mulder, A Laenen, H Wildiers, K Punie, A Poppe, C Remmerie, I Nevelsteen, A Smeets, E Van Nieuwenhuysen, E Van Limbergen, G Floris, I Vergote and P Neven
H De Mulder
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Laenen
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H Wildiers
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K Punie
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Poppe
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Remmerie
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I Nevelsteen
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Smeets
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Van Nieuwenhuysen
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Van Limbergen
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Floris
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I Vergote
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P Neven
KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium; Interuniversity Centre for Biostatistics and Statistical Bioinformatics, Leuven, Vlaams-Brabant, Belgium; KU Leuven - University of Leuven, University Hospitals Leuven, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.SABCS16-P6-09-32 Published February 2017
  • Article
  • Info & Metrics
Loading
Abstracts: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas

Abstract

Background: Pregnancy affects breast cancer risk but it's influence on breast cancer subtype and prognosis remains controversial. We studied the effect of parity and time since last birth on breast cancer subtype and outcome in women aged ≤50 years at diagnosis.

Patients and Methods: A retrospective multivariate cohort study including all premenopausal women aged ≤50 years (N=1306) at diagnosis and primarily treated with surgery (N=1176) or neo-adjuvant chemotherapy (N=130) at University Hospitals Leuven (Jan. 2000 – Dec. 2009); local and systemic therapies were consistent with guidelines when treated. Tumor subtypes were defined by tumor grade and receptor expression for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) amplification; ER+PR+/-HER-2- cases were Luminal A- like if grade 1-2 and Luminal B like if grade 3; HER-2+ cases were Luminal HER-2 if ER+ and HER-2 like if ER-; triple negative breast cancer (TNBC) were ER-PR-HER-2-. Outcome endpoints were breast cancer subtype, disease free (DFS) and distant disease free survival (DDFS) by parity and in parous women comparing short (<5 years) versus long (≥5 years) time since last birth. Statistics used were Cox proportional hazard model. Results were corrected for age at diagnosis, tumor size, lymph node status and tumor subtype.

Results: Breast cancer subtypes didn't differ between nulliparous and parous women but subtypes differed significantly in parous women by time interval since last birth (p<0.001). Breast cancers within 5 years of last birth were proportionally more likely TNBC and HER-2 like compared to Luminal A (p=0.026 and p=0.003 respectively) than breast cancers ≥5 years after last birth even when corrected for age at diagnosis. After a mean follow-up period of 10 years, parous women had a better DFS compared to nulliparous women (DFS: HR 0.754; CI 0.593-0.959; p=0.021) but after correction for known prognostic factors, only a trend remained (HR 0.783; CI 0.611-1.004; p=0.054). In parous women, those with a longer time interval since last birth had a better DFS than women with a recent pregnancy (HR 0.965; CI 0.948-0.982; p<0.001). However, after correction for known prognostic factors, this association was completely attenuated (HR 0.997; CI 0.972-1.023; p=0.828). Comparable results were seen for DDFS.

Conclusion: After correction for age at diagnosis, parity does not but recent birth does affect breast cancer subtype. Such tumors are proportionally more likely ER-negative namely TNBC and HER-2 like. We observed a trend for better DFS for parous women. The prognostic value of time since last birth is mostly due to tumor characteristics and age at time of diagnosis.

Citation Format: De Mulder H, Laenen A, Wildiers H, Punie K, Poppe A, Remmerie C, Nevelsteen I, Smeets A, Van Nieuwenhuysen E, Van Limbergen E, Floris G, Vergote I, Neven P. The association of breast cancer subtype and breast cancer survival with parity and time since last birth [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P6-09-32.

Previous
Back to top
Cancer Research: 77 (4 Supplement)
February 2017
Volume 77, Issue 4 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract P6-09-32: The association of breast cancer subtype and breast cancer survival with parity and time since last birth
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract P6-09-32: The association of breast cancer subtype and breast cancer survival with parity and time since last birth
H De Mulder, A Laenen, H Wildiers, K Punie, A Poppe, C Remmerie, I Nevelsteen, A Smeets, E Van Nieuwenhuysen, E Van Limbergen, G Floris, I Vergote and P Neven
Cancer Res February 15 2017 (77) (4 Supplement) P6-09-32; DOI: 10.1158/1538-7445.SABCS16-P6-09-32

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract P6-09-32: The association of breast cancer subtype and breast cancer survival with parity and time since last birth
H De Mulder, A Laenen, H Wildiers, K Punie, A Poppe, C Remmerie, I Nevelsteen, A Smeets, E Van Nieuwenhuysen, E Van Limbergen, G Floris, I Vergote and P Neven
Cancer Res February 15 2017 (77) (4 Supplement) P6-09-32; DOI: 10.1158/1538-7445.SABCS16-P6-09-32
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Poster Session Abstracts

  • Abstract P6-14-05: Phase 2 study evaluating the efficacy and safety of eribulin mesylate administered biweekly for patients with human epidermal growth factor receptor 2-negative metastatic breast cancer
  • Abstract P6-08-07: Decline in compliance to breast cancer screening in France: Results of the 5th EDIFICE survey
  • Abstract P6-08-04: National trends in mastectomy for operable breast cancers treated with neoadjuvant chemotherapy
Show more 3

Prognostic and Predictive Factors: Prognostic and Predictive Factors - Other

  • Abstract P6-09-11: Genetic variation in CYP3A affects steady-state exemestane concentrations but does not explain inter-race difference
  • Abstract P6-09-37: Ductal carcinoma in situ: Patient outcomes and association with hormone receptors
  • Abstract P6-09-38: Interaction between body mass index and hormone receptor status as a prognostic factor in node-positive breast cancer
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement